About The Study: The findings of this cohort study suggest that glucagon-like peptide–1 receptor agonist (GLP-1 RA) use was associated with significant reduction in all-cause mortality among patients ...

Recently, there has been a lot of news around the use of peptides in health circles. The US Department of Health and Human ...

GLP-1 drugs are driving major weight loss trends, but doctors warn that rapid weight loss may affect nutrition, bone density, heart health, and blood sugar balance.

The University of Michigan celebrated the 21st anniversary of its annual V-BID Summit on March 11, 2026, highlighting pathways to improve value-based insurance design and ensuring ...

Performance-enhancing peptides are increasingly popular among fitness enthusiasts and biohackers, despite limited human ...

GLP-1 receptor agonist use was linked to a significantly higher risk for osteoporosis, gout, and osteomalacia over 5 years.

From 2023, there was a decrease in use of metabolic and bariatric surgery, with stronger decline for sleeve gastrectomy.

The UK is one of the heaviest nations in Europe now with 64 per cent of the population overweight or obese, and one in four ...

GLP-1 receptor agonists appear to be associated with an increased risk for osteoporosis and other orthopedic conditions.

CDSCO has asked drugmakers to stop obesity awareness campaigns linked to GLP-1 drugs, warning that such activities could amount to misleading promotion of prescription medicines ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss appear to be similarly effective among adults across ages, races, and starting weights, according to a review published online ...